Schedule 13G ownership disclosure

Oruka Therapeutics Inc

Common Stock, $0.001 par value · CUSIP: 687604108

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • RTW Investments, LP

    Shares: 2,058,148.00 · Class: 4.3%

  • Roderick Wong

    Shares: 2,058,148.00 · Class: 4.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493215-26-000040
Form type
SCHEDULE 13G/A
Filer
Oruka Therapeutics, Inc.
CIK
CIK 907654
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub